Abstract

Simple SummaryCell therapy has become a powerful method for regenerative medicine. However, there has not been an ideal cell type and cell source for the treatment of neurological diseases such as Parkinson’s disease and Alzheimer’s disease. This review aims to introduce the potentials of different cells for treating neurological disorders by collecting the results from related clinical trials and recent animal studies. It is an overview of some promising cells that may be clinically used for neurological disorders. The characteristics of each cell type and the main mechanism of function are also described.Neurological disorders are big public health challenges that are afflicting hundreds of millions of people around the world. Although many conventional pharmacological therapies have been tested in patients, their therapeutic efficacies to alleviate their symptoms and slow down the course of the diseases are usually limited. Cell therapy has attracted the interest of many researchers in the last several decades and has brought new hope for treating neurological disorders. Moreover, numerous studies have shown promising results. However, none of the studies has led to a promising therapy for patients with neurological disorders, despite the ongoing and completed clinical trials. There are many factors that may affect the outcome of cell therapy for neurological disorders due to the complexity of the nervous system, especially cell types for transplantation and the specific disease for treatment. This paper provides a review of the various cell types from humans that may be clinically used for neurological disorders, based on their characteristics and current progress in related studies.

Highlights

  • IntroductionThere are more than 600 neurological disorders that can be divided into four categories: (1) sudden onset conditions, such as stroke; (2) intermittent conditions, such as epilepsy; (3) progressive conditions, such as Parkinson’s disease (PD); (4) stable neurological conditions, such as cerebral palsy

  • Neurological disorders are defined as diseases of the nervous system

  • Various types of cells have been used in cell therapy studies, including embryonic stem cells (ESCs), induced pluripotent stem cells, neural stem/progenitor cells (NSPCs), mesenchymal stromal/stem cells (MSCs), and olfactory ensheathing cells (OECs), etc

Read more

Summary

Introduction

There are more than 600 neurological disorders that can be divided into four categories: (1) sudden onset conditions, such as stroke; (2) intermittent conditions, such as epilepsy; (3) progressive conditions, such as Parkinson’s disease (PD); (4) stable neurological conditions, such as cerebral palsy. These diseases have become a big public health challenge and present a tremendous burden to individuals, their families, and society. Despite the promising results from numerous animal-based studies, the outcomes from clinical trials are normally not as significant as from animal studies This may be due to the difference between animal models and the real disease of patients and the differences in nervous systems between animals and humans. The aim of this review is to summarize the cells that may be clinically used for neurological disorders, especially for the diseases mentioned above, and their characteristics and current progresses in related studies

Cell Source
Procedures
Different Cell Types and the Current Progress
Muse Cells
Discussion
Findings
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call